AskBio Completes Phase 2 Enrollment for Heart Failure Gene Therapy
RESEARCH TRIANGLE PARK, N.C., USA, March 31, 2026 AskBio, a wholly owned and independently operated subsidiary of Bayer AG,...
Alzheimer’s Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy GMP GMP compliance Immuno-Oncology immunology Immunotherapy Medical Devices MedTech medtech innovation Monoclonal Antibody NSCLC Oncology oncology innovation Orphan Drug orphan drug designation patient access Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory approval regulatory compliance targeted therapy
RESEARCH TRIANGLE PARK, N.C., USA, March 31, 2026 AskBio, a wholly owned and independently operated subsidiary of Bayer AG,...
TUCSON, Ariz., Feb. 12, 2026 — Picard Medical, parent company of SynCardia Systems, announced a landmark bridge-to-transplant milestone at...
MADRID & NEW YORK, January 29, 2026 — A multicenter randomized clinical trial has demonstrated that remote dielectric sensing...
BORDEAUX, France | January 9, 2026 — FineHeart S.A., a French clinical-stage MedTech company, has secured €83 million in...
Dateline – November 17, 2025 | San Jose, California Anixa Biosciences, Inc. announced that the WHO’s International Non-proprietary Names...
Dateline – November 17, 2025 | Bengaluru, India In a significant development for India’s pharmaceutical ecosystem, AstraZeneca Pharma India...
NEW YORK, November 13, 2024 — Cardiol Therapeutics has secured a U.S. patent allowance protecting its next-generation cardiac therapies...
